Schwannoma

Also known as: 신경초종 쉬반종, 시반종

Neurosurgery doctors

Doctors who treat Schwannoma

See all
Seoul St. Mary's Hospital, Catholic University of Korea Jung Yang-guk

Jung Yang-guk

Seoul St. Mary's Hospital, Catholic University of Korea · Orthopedic Surgery

수부상지 질환 및 말초신경질환 질환,골연부조직 종양

5.0
St. Vincent's Hospital, Catholic University of Korea Kim Il-seop

Kim Il-seop

St. Vincent's Hospital, Catholic University of Korea · Neurosurgery

척추질환(경추, 요추 디스크, 협착증, 척추종양, 척추 수술후 증후군), 척추외상, 말초신경질환

5.0
Konyang University Hospital Kim Hyeon-u

Kim Hyeon-u

Konyang University Hospital · Neurosurgery

척추증, 척추디스크, 협착증, 척추외상, 척추종양

3.0
Eunpyeong St. Mary's Hospital, Catholic University of Korea Hong Jae-taek

Hong Jae-taek

Eunpyeong St. Mary's Hospital, Catholic University of Korea · Neurosurgery

경추·요추 디스크 및 상·하지 방사통, 노인성 척추질환, 척추수술 후 증후군, 말초신경 질환, 척추종양 및 척수종양

Kyung Hee University Hospital Yoon Seong-sang

Yoon Seong-sang

Kyung Hee University Hospital · Neurology

뇌졸중, 두통, 말초신경병, 운동성질환, 어지럼증

Seoul St. Mary's Hospital, Catholic University of Korea Nam Gyeong-eun

Nam Gyeong-eun

Seoul St. Mary's Hospital, Catholic University of Korea · Rehabilitation Medicine

근골격계 통증,심장 및 호흡(폐)재활,근전도,말초신경질환

Bucheon St. Mary's Hospital, Catholic University of Korea Park Il-jung

Park Il-jung

Bucheon St. Mary's Hospital, Catholic University of Korea · Orthopedic Surgery

수부 및 수근관절, 주관절(팔꿈치), 미세혈관질환 및 말초신경질환, 수부관절 관련 외상 ◆급·만성 감염성 질환(봉와직염, 화농성 근염, 골수염, 화농성 관절염 등) 제외◆

St. Vincent's Hospital, Catholic University of Korea Kim Ji-yong

Kim Ji-yong

St. Vincent's Hospital, Catholic University of Korea · Neurosurgery

척추질환(경추, 요추 디스크, 협착증, 척추종양, 척추 수술후 증후군), 척추외상, 말초신경질환

Nowon Eulji University Hospital Bae In-seok

Bae In-seok

Nowon Eulji University Hospital · Neurosurgery

퇴행성척추질환, 척추종양, 척추외상, 최소침습척추수술, 손발저림, 말초신경질환, 두부외상

Nowon Eulji University Hospital Jwa Cheol-su

Jwa Cheol-su

Nowon Eulji University Hospital · Neurosurgery

요통, 디스크 질환, 척추관 협착증, 골다공증, 척추손상, 뇌손상, 손발저림, 말초신경질환, 뇌출혈

Schwannoma (Schwannoma)

1) Disease Description (Causes and Symptoms)

  • Definition and causes
    • Schwannomas are mostly benign peripheral nerve sheath tumors that arise from Schwann cells, which surround nerves. Most are solitary lesions that grow slowly. Rarely, they may be associated with neurofibromatosis (e.g., neurofibromatosis type 2, NF2) and present as multiple, bilateral lesions.
  • Pathophysiology
    • As the tumor compresses or displaces the nerve from which it arose, it gradually impairs the function of that nerve. Symptoms vary depending on the site of origin, such as the cranial nerves (especially the auditory/vestibular nerve), spinal nerves, or peripheral nerves.
  • Main symptoms (summary by location)
    • Inner ear (auditory nerve/vestibular nerve) origin (most common): early tinnitus, progressive hearing loss (especially reduced speech understanding), balance problems (vertigo, dizziness).
    • Trigeminal nerve involvement: decreased facial sensation or numbness.
    • Facial nerve involvement: facial paralysis, facial muscle weakness.
    • Spinal nerve origin: localized pain, sensory disturbances, motor weakness, and, with progression, paraplegia and urinary or bowel dysfunction (sphincter dysfunction).
    • Large intracranial lesion: symptoms of increased intracranial pressure, including headache, vomiting, decreased consciousness, and hydrocephalus.
  • Other
    • Most grow slowly (an average of several millimeters per year), but some may enlarge rapidly. Malignant transformation is extremely rare.

2) Treatment Methods (Standard Treatment, Medications, Procedures/Surgery, Lifestyle Management and Precautions)

  • Diagnostic principles
    • Definitive diagnosis is primarily made based on imaging and clinical findings. Preoperative biopsy is generally not performed (with exceptions depending on lesion accessibility and the treatment plan).
  • Standard treatment options
    • Observation (regular MRI)
      • Chosen for small, asymptomatic lesions or for older patients and patients at high risk from surgery. If there is no growth during the first year, the lesion often remains stable thereafter as well.
    • Radiosurgery (stereotactic radiotherapy, e.g., Gamma Knife/CyberKnife/LINAC)
      • Effective for small- to medium-sized lesions or residual/recurrent lesions after surgery. Hearing preservation may be an objective, but hearing loss may continue to progress even after radiation.
    • Microsurgical resection (craniotomy or spinal approach)
      • First-line treatment when symptoms are present, the lesion is moderate or larger in size, or there is acute deterioration of neurological function. The surgical approach varies according to the lesion’s location (for example, for a vestibular schwannoma associated with the posterior cranial fossa, a posterior temporal fossa approach may be used) (e.g., retrosigmoid, translabyrinthine, middle fossa).
  • Medications and conservative treatment
    • There are no medications that shrink the tumor itself. Short-term steroids may be used in cases of acute edema or worsening symptoms.
    • Symptomatic treatment for pain and vertigo (analgesics, antiemetics, medications for otolith-related dizziness, etc.).
  • Lifestyle management and precautions
    • Regular imaging follow-up (MRI with contrast recommended) and hearing and neurological function tests (audiometry, facial nerve assessment, evaluation of urinary function, etc.) are recommended.
    • Be sure to report whether you are taking anticoagulants and any surgery-related history, such as a nasal implant.
    • Immediate emergency medical attention is necessary if sudden decreased consciousness, severe headache, severe vomiting, or a new progressive neurological deficit occurs.
  • Risks of complications and precautions
    • Surgery: facial nerve paralysis, hearing loss (especially depending on the approach), CSF leakage, infection, brain injury, bleeding, hydrocephalus, etc.
    • Radiotherapy: post-radiation inflammation, worsening of neurological function (delayed hearing loss in some patients), and, very rarely, radiation-induced malignant transformation.
    • Long-term prognosis: Most are benign and have little effect on overall survival, but neurological deficits (hearing, facial movement, paralysis, etc.) may remain permanent.

3) Checklist Before an Outpatient Visit (Including Items to Bring, Test Records, and Example Questions)

  • Items and documents to bring
    • List of currently used medications (including anticoagulants and antiplatelet drugs)
    • Records of previous surgery, anesthesia, and allergies
    • Existing radiology records (films or digital images and reports from recent MRI/CT scans)
    • Recent hearing test (audiogram), vestibular function test (if available), and neurological examination results
    • Symptom diary (when symptoms began, when they worsened, patterns, and triggers) and lifestyle habits (smoking and alcohol use)
  • Key information to provide to the doctor in advance during the outpatient visit
    • The rate of progression of symptom changes (e.g., worsening hearing, dizziness, facial sensory abnormalities)
    • Whether you are taking anticoagulants (important when planning surgery)
  • Basic example questions to ask the doctor during the outpatient visit
    • (Examples are provided separately in the next section)

4) Examples of General Questions to Ask the Doctor

  • What is the expected growth rate of this lesion, and what is the expected interval between follow-up tests?
  • In my case, is surgery necessary, or would observation or radiosurgery also be possible?
  • What are the advantages and disadvantages of the recommended treatment, and what complications are expected (especially those related to the facial nerve and hearing)?
  • What is the prognosis after treatment (including hearing preservation and recovery of motor function)?
  • Will restrictions on daily activities, exercise, or driving be necessary before or after treatment?
  • If surgery is performed, what are the expected anesthesia and hospitalization periods and the expected recovery time?

5) Examples of Disease-Specific Questions

  • If an auditory nerve (vestibular nerve) schwannoma is suspected
    • "Given my current hearing status, how likely is hearing preservation? Which treatment (surgical approach/radiosurgery) is more favorable for preserving hearing?"
    • "If I choose Gamma Knife (stereotactic radiosurgery), how are my hearing and facial nerve function likely to change in the long term?"
  • If a spinal or peripheral nerve schwannoma is suspected (when motor or urinary dysfunction is present)
    • "How much recovery of neurological function (motor, sensory, urinary, and bowel function) do you expect after surgery? What is the expected time window for recovery?"

Summary: Schwannoma is a mostly benign nervous system tumor originating from Schwann cells. Depending on its location, it can cause hearing loss, vertigo, facial paralysis, paralysis of the limbs, and sphincter dysfunction. Treatment is determined according to the patient’s condition and the tumor’s characteristics and may include observation, radiosurgery, or microsurgical resection. Regular imaging follow-up and neurological function testing are important.

Patient stories: Schwannoma

Talk with other Schwannoma patientsAsk people who have been through itWrite

Hospitals that treat Schwannoma

University hospitals where the doctors above see patients. Open a hospital to see its doctors by specialty and how to book.

Other conditions in Neurosurgery

Condition guide
Find top doctors for 'Schwannoma'

Reviewed by · GoodDoctorNet medical specialists

This information is for general understanding only and does not replace diagnosis, prescription or treatment for an individual patient. If you have symptoms, please see a doctor.

Our medical content policy (in Korean) →